We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$228B
AUM Growth
+$29.9B
Cap. Flow
+$21.5B
Cap. Flow %
9.45%
Top 10 Hldgs %
22.25%
Holding
10,525
New
1,702
Increased
3,804
Reduced
3,457
Closed
1,419

Sector Composition

Rank Sector Weight
1 Technology 2.03%
2 Consumer Discretionary 1.46%
3 Financials 1.01%
4 Healthcare 0.92%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPCH icon
8576
Option Care Health
OPCH
$3.6B
$118K ﹤0.01%
+10,839
New +$82.4K
ALLT icon
8577
PUT
Allot
ALLT
$374M
$117K ﹤0.01%
+23,000
New +$113K
INVE icon
8578
PUT
Identive
INVE
$69.8M
$117K ﹤0.01%
22,200
+10,800
+95% +$61.5K
VANI icon
8579
Vivani Medical
VANI
$128M
$117K ﹤0.01%
3,872
-9,154
-70% -$259K
TCS
8580
PUT
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$117K ﹤0.01%
1,313
-1,694
-56% -$122K
KDNY
8581
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$117K ﹤0.01%
2,060
-1,080
-34% -$54.2K
MACK
8582
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$117K ﹤0.01%
11,973
-15,328
-56% -$313K
PTM
8583
DELISTED
E-TRACS UBS Long Platinum ETN
PTM
$117K ﹤0.01%
12,147
GALT icon
8584
CALL
Galectin Therapeutics
GALT
$419M
$116K ﹤0.01%
47,000
+8,800
+23% +$23.4K
GUT
8585
Gabelli Utility Trust
GUT
$573M
$116K ﹤0.01%
+17,062
New +$114K
LCTX icon
8586
Lineage Cell Therapeutics
LCTX
$283M
$116K ﹤0.01%
41,960
-10,881
-21% -$30.4K
PLX icon
8587
CALL
Protalix BioTherapeutics
PLX
$200M
$116K ﹤0.01%
13,910
+8,620
+163% +$80.9K
ASXC
8588
DELISTED
Asensus Surgical, Inc.
ASXC
$116K ﹤0.01%
+12,597
New +$120K
JONE
8589
CALL
DELISTED
Jones Energy, Inc.
JONE
$116K ﹤0.01%
3,635
-285
-7% -$11.5K
LRMR icon
8590
PUT
Larimar Therapeutics
LRMR
$433M
$115K ﹤0.01%
2,742
-125
-4% -$6.39K
MFIN icon
8591
CALL
Medallion Financial
MFIN
$269M
$115K ﹤0.01%
48,000
+35,900
+297% +$81.8K
ASFI
8592
DELISTED
Asta Funding Inc
ASFI
$115K ﹤0.01%
+13,980
New +$106K
BCLI
8593
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$114K ﹤0.01%
1,820
-2,233
-55% -$138K
DRD
8594
DRDGold
DRD
$2.6B
$114K ﹤0.01%
+36,339
New +$137K
EVC icon
8595
CALL
Entravision Communication
EVC
$737M
$114K ﹤0.01%
17,300
-109,100
-86% -$661K
MGNI icon
8596
CALL
Magnite
MGNI
$3.35B
$114K ﹤0.01%
22,100
-17,600
-44% -$96.7K
EIGR
8597
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$114K ﹤0.01%
+480
New +$109K
PCTI
8598
DELISTED
PCTEL, Inc. Common Stock
PCTI
$114K ﹤0.01%
+16,109
New +$113K
HIL
8599
DELISTED
Hill International, Inc. Common Stock
HIL
$114K ﹤0.01%
+21,900
New +$99.4K
GV
8600
PUT
DELISTED
Goldfield Corporation
GV
$114K ﹤0.01%
20,700
+4,300
+26% +$21.1K

Similar funds

Jeff Yass's Q2 2017 Portfolio in Review

As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass deployed $21.5B of net new capital in Q2 2017, opening 1,702 new positions and adding to 3,804 existing holdings. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $353M trimmed.

  • Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
  • Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
  • Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
  • Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
  • Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
  • Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
  • Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.